Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Kidney Disease Investigation(Electronic Edition) ›› 2015, Vol. 04 ›› Issue (05): 232-235. doi: 10.3877/cma.j.issn.2095-3216.2015.05.003

Special Issue:

• Expert Forums • Previous Articles     Next Articles

Diagnosis and treatment of C1q nephropathy

Zhaohui Ni1,(), Haijiao Jin1, Weijia Xu1   

  1. 1. Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China
  • Online:2015-10-28 Published:2015-10-28
  • Contact: Zhaohui Ni
  • About author:
    Corresponding author: Ni Zhaohui, Email:

Abstract:

C1q nephropathy is a glomerular disorder with prominent mesangial proliferation. It is characterized by mesangial dense deposits under electron microscopy and C1q deposits under immunofluorescence microscopy. The histologic pattern of C1q nephropathy can be divided into three kinds: minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and immune-mediated proliferative glomerulonephritis. Its clinical presentation is heterogenous, ranging from nephritic to nephrotic proteinuria, with or without hematuria and renal insufficiency. Glucocorticoids remain the mainstay of treatment. Most studies indicated poor response of C1q nephropathy to glucocorticoids. The treatment of integrated Chinese and western medicine for C1q nephropathy is promising.

Key words: C1q nephropathy, Clinical presentation, Histologic pattern, Treatment

京ICP 备07035254号-35
Copyright © Chinese Journal of Kidney Disease Investigation(Electronic Edition), All Rights Reserved.
Tel: 010-66937011 E-mail: zhsbyj@126.com
Powered by Beijing Magtech Co. Ltd